Kala Pharmaceuticals, Inc.
Crystalline forms of therapeutic compounds and uses thereof

Last updated:

Abstract:

Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

26 Feb 2019

Issue date:

1 Jun 2021